← Eichor
Study identifier: NCT07283042 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of Clinical Outcomes and Acceptability of an Anatomical Classification for Placenta Accreta Spectrum

Condition: Placenta Accreta  ·  Sponsor: University of California, Los Angeles

PhaseN/A
Planned participants60
Who can joinFemale, 18 Years to 55 Years
Healthy volunteersNo

About this study

This study evaluates the clinical implementation of intra-operative topographic classification system for PAS. In addition to a standard of care risk stratification prenatal ultrasound for patients with a risk of PAS, this study adds an additional intraoperative surgical staging protocol to validate the classification system, improve surgical approach, and significantly clinical outcomes of pregnant people with an a prior risk of PAS. The study will involve pregnant patients with PAS risk factor, include data collection spanning prenatal assessment, intraoperative classification, surgical technique implementation and postoperative analysis. The anticipated study duration is approximately 36-48 months.

This description comes directly from the study's public registry record.

Talk to the study team

Dana Levin-Lopez, MPH  ·  310-794-8893  ·  dlevinlopez@mednet.ucla.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of California, Los AngelesLos Angeles, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07283042